basiliximab

Known as: Ig gamma-1 chain C region, basiliximab [Chemical/Ingredient], chimeric mouse-human antiCD25 
A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha) with… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Pediatric renal transplant recipients were enrolled in a multicenter, randomized, double-blind trial of steroid withdrawal… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Induction therapy reduces the frequency of acute rejection and delayed graft function after transplantation. A rabbit… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
This study examined alemtuzumab (anti-CD 52, Campath-1H) and basiliximab (anti-CD 25, Simulect) as induction immunosuppression in… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Sequential anti-thymocyte globulins (ATG)/cyclosporine immunosuppression has two main advantages: delayed introduction… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Acute graft rejection remains a major problem in renal transplant recipients, and there is no consensus on the optimal… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Progressive nephrotoxicity caused by calcineurin inhibitor drugs contributes to the long-term decline in renal… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND A double-blind, placebo-controlled phase III study was performed to assess whether basiliximab, a chimeric anti… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND Currently available immunosuppressive regimens for cadaver-kidney recipients are far from ideal because acute… (More)
Is this relevant?